MISSION: GliomaS
Research type
Research Study
Full title
A physiological exploratory study to assess tissue structure and metabolism in Glioma using sodium-23 Magnetic Resonance Imaging (23Na-MRI).
IRAS ID
204201
Contact name
Fulvio Zaccagna
Contact email
Sponsor organisation
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
Cancer cells undergo a change in structure and an increase in metabolism that can be imaged using Sodium-23 magnetic resonance imaging (23Na-MRI), Hyperpolarized Carbon-13 magnetic resonance spectroscopic imaging (13C-MRSI) and other novel techniques, such as Diffusion Kurtosis Imaging (DKI). These techniques will be investigated in this trial. The development, optimization and validation of these techniques may provide a deeper understanding of the physiology of cancer with a significant improvement in diagnosis and management of patients with gliomas.
REC name
East of England - Cambridge South Research Ethics Committee
REC reference
16/EE/0184
Date of REC Opinion
14 Jul 2016
REC opinion
Further Information Favourable Opinion